Skip to main content

Advertisement

Log in

The effects of antiretroviral treatment initiation on cognition in HIV-infected individuals with advanced disease in Pune, India

  • Published:
Journal of NeuroVirology Aims and scope Submit manuscript

Abstract

There has been a reduction in the most severe cases of HIV-associated neurocognitive disorders (HAND) with advances in antiretroviral treatment (ART). But the prevalence of milder forms of HAND still remains high. Data from systematically conducted studies on the effects of ART on cognition are scanty in India, where HIV-1 clade C is prevalent. The purpose of the present study was to assess the effect of antiretroviral therapy in HIV-seropositive (HIV+) individuals (n = 92) with CD4 cell counts <200 cells/mm3. The overall and domain-specific levels of cognitive functioning were determined using a locally recruited normative sample, and a change in neurocognitive functioning at the 1-year follow-up visit was analyzed. Results revealed cognitive impairment in 44.6 % of the HIV+ group at baseline. At the 1-year follow-up, the group showed significant improvement in the Learning domain (p < 0.05). HIV+ individuals showing improvement in the global cognitive scores had a significantly lower baseline CD4 cell count compared to others. Overall, the degree of improvement associated with the magnitude of rise in CD4 suggests the possibility that early, mild subclinical deficits may also benefit from treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  • Al-Khindi T, Zakzanis KK, van Gorp WG (2011) Does antiretroviral therapy improve HIV-associated cognitive impairment? A quantitative review of the literature. J Int Neuropsychol Soc 17:956–969

    Article  PubMed  Google Scholar 

  • Becker JT, Sanchez J, Dew MA, Lopez OL, Dorst SK, Banks G (1997) Neuropsychological abnormalities among HIV-infected individuals in a community-based sample. Neuropsychology 11:592–601

    Article  CAS  PubMed  Google Scholar 

  • Buonaguro L, Tornesello ML, Buonaguro FM (2007) Human immunodeficiency virus type 1 subtype distribution in the worldwide epidemic: pathogenetic and therapeutic implications. J Virol 81:10209–10219

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Cohen RA, Boland R, Paul R, Tashima KT, Schoenbaum EE, Celentano DD, Schuman P, Smith DK, Carpenter CC (2001) Neurocognitive performance enhanced by highly active antiretroviral therapy in HIV-infected women. AIDS 15:341–345

    Article  CAS  PubMed  Google Scholar 

  • Cross HM, Cobrinck MI, Joska JA (2013) HIV-associated neurocognitive disorders: antiretroviral regimen, central nervous system penetration effectiveness, and cognitive outcomes. S Afr Med J 103(10):758–762

    Article  CAS  PubMed  Google Scholar 

  • Cysique LA, Brew BJ (2009) Neuropsychological functioning and antiretroviral treatment in HIV/AIDS: a review. Neuropsychol Rev 19:169–185

    Article  PubMed  Google Scholar 

  • Cysique LA, Brew BJ (2011) Prevalence of non-confounded HIV-associated neurocognitive impairment in the context of plasma HIV RNA suppression. J Neurovirol 17:176–183

    Article  PubMed  Google Scholar 

  • Cysique LA, Maruff P, Brew BJ (2006) Variable benefit in neuropsychological function in HIV-infected HAART-treated patients. Neurology 66:1447–1450

    Article  PubMed  Google Scholar 

  • Cysique LA, Vaida F, Letendre S, Gibson S, Cherner M, Woods SP, McCutchan JA, Heaton RK, Ellis RJ (2009) Dynamics of cognitive change in impaired HIV-positive patients initiating antiretroviral therapy. Neurology 73:342–348

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Cysique LA, Letendre SL, Ake C, Jin H, Franklin DR, Gupta S, Shi C, Yu X, Wu Z, Abramson IS, Grant I, Heaton RK, HIV Neurobehavioral Research Center Group (2010) Incidence and nature of cognitive decline over 1 year among HIV-infected former plasma donors in China. AIDS 24:983–990

    Article  PubMed Central  PubMed  Google Scholar 

  • Cysique LA, Waters EK, Brew BJ (2011) Central nervous system antiretroviral efficacy in HIV infection: a qualitative and quantitative review and implications for future research. BMC Neurol 11:148

    Article  PubMed Central  PubMed  Google Scholar 

  • Grant I, Atkinson JH (2000) Neuropsychiatric aspects of HIV infection and AIDS. In: Sadock BJ, Sadock VA (eds) Kaplan & Sadock’s comprehensive textbook of psychiatry, vol 1 & 2, 7th edn. Lippincott Williams & Wilkins Publishers, Philadelphia, pp 308–333

    Google Scholar 

  • Gupta JD, Satishchandra P, Gopukumar K, Wilkie F, Waldrop-Valverde D, Ellis R, Ownby R, Subbakrishna DK, Desai A, Kamat A (2007) Neuropsychological deficits in human immunodeficiency virus type 1 clade C-seropositive adults from South India. J Neurovirol 13:195–202

    Article  PubMed  Google Scholar 

  • Heaton RK, Grant I, Butters N, White DA, Kirson D, Atkinson JH, McCutchan JA, Taylor MJ, Kelly MD, Ellis RJ et al (1995) The HNRC 500-neuropsychology of HIV infection at different disease stages. HIV neurobehavioral research center. J Int Neuropsychol Soc 1:231–251

    Article  CAS  PubMed  Google Scholar 

  • Heaton RK, Cysique LA, Jin H, Shi C, Yu X, Letendre S, Franklin DR, Ake C, Vigil O, Atkinson JH, Marcotte TD, Grant I, Wu Z, San Diego HIV Neurobehavioral Research Center Group (2008) Neurobehavioral effects of human immunodeficiency virus infection among former plasma donors in Rural China. J Neurovirol 14:536–549

    Article  PubMed Central  PubMed  Google Scholar 

  • Heaton RK, Clifford DB, Franklin DR Jr, Woods SP, Ake C, Vaida F, Ellis RJ, Letendre SL, Marcotte TD, Atkinson JH et al (2010) HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER study. Neurology 75:2087–2096

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Heaton RK, Franklin DR Jr, Deutsch R, Letendre SL, Ellis RJ, Casaletto K, Marquine MJ, Woods SP, Vaida F, Atkinson JH, Marcotte TD, McCutchan JA, Collier AC, Marra CM, Clifford DB, Gelman BB, Sacktor N, Morgello S, Simpson DM, Abramson I, Gamst A, Fennema-Notestine C, Smith DM, Grant I, for the CHARTER Group (2014) Neurocognitive change in the era of HIV combination antiretroviral therapy: a longitudinal CHARTER study. Clin Infect Dis 60(3):473–480

    Article  PubMed  Google Scholar 

  • Highleyman L (2009) HIV and the brain. BETA 10:16–29

    Google Scholar 

  • Joska JA, Gouse H, Paul RH, Stein DJ, Flisher AJ (2010) Does highly active antiretroviral therapy improve neurocognitive function? A systematic review. J Neurovirol 16:101–114

    Article  CAS  PubMed  Google Scholar 

  • Joska JA, Westgarth-Taylor J, Myer L, Hoare J, Thomas KG, Combrinck M, Paul RH, Stein DJ, Flisher AJ (2011) Characterization of HIV-associated neurocognitive disorders among individuals starting antiretroviral therapy in South Africa. AIDS Behav 15:1197–1203

    Article  PubMed  Google Scholar 

  • Joska JA, Westgarth-Taylor J, Hoare J, Thomas KG, Paul R, Myer L, Stein DJ (2012) Neuropsychological outcomes in adults commencing highly active anti-retroviral treatment in South Africa: a prospective study. BMC Infect Dis 12

  • Letendre SL, McCutchan JA, Childers ME, Woods SP, Lazzaretto D, Heaton RK, Grant I, Ellis RJ, HNRC Group (2004) Enhancing antiretroviral therapy for human immunodeficiency virus cognitive disorders. Ann Neurol 56:416–423

    Article  PubMed  Google Scholar 

  • Letendre S, Marquie-Beck J, Capparelli E, Best B, Clifford D, Collier AC, Gelman BB, McArthur JC, McCutchan JA, Morgello S, Simpson D, Grant I, Ellis RJ, CHARTER Group (2008) Validation of the CNS penetration-effectiveness rank for quantifying antiretroviral penetration into the central nervous system. Arch Neurol 65:65–70

    Article  PubMed Central  PubMed  Google Scholar 

  • Letendre S, Ellis RJ, Best B, Bhatt A, Marquie-Beck J, LeBlanc S et al (2009) Penetration and effectiveness of antiretroviral therapy in the central nervous system. Anti-Inflammatory Anti-Allergy Agents Med Chem 8:169–183

    Article  CAS  Google Scholar 

  • Marra CM, Lockhart D, Zunt JR, Perrin M, Coombs RW, Collier AC (2003) Changes in CSF and plasma HIV-1 RNA and cognition after starting potent antiretroviral therapy. Neurology 60:1388–1390

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • McArthur JC, Brew BJ, Nath A (2005) Neurological complications of HIV infection. Lancet Neurol 9:543–555

    Article  Google Scholar 

  • National guidelines (2007) http://naco.gov.in/upload/Policies%20&%20Guidelines/1.%20Antiretroviral%20Therapy%20Guidelines%20for%20HIV-Infected%20Adults%20and%20Adolescents%20Including%20Post-exposure.pdf. Accessed on September 29, 2014

  • Obiabo YO, Ogunrin OA, Ogun AS (2012) Effects of highly active antiretroviral therapy on cognitive functions in severely immune-compromised HIV-seropositive patients. J Neurol Sci 313:115–122

    Article  CAS  PubMed  Google Scholar 

  • Ranga U, Shankarappa R, Siddappa NB, Ramakrishna L, Nagendran R, Mahalingam M, Mahadevan A, Jayasuryan N, Satishchandra P, Shankar SK, Prasad VR (2004) Tat protein of human immunodeficiency virus type 1 subtype C strains is a defective chemokine. J Virol 78:2586–2590

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Robertson KR, Robertson WT, Ford S, Watson D, Fiscus S, Harp AG, Hall CD (2004) Highly active antiretroviral therapy improves neurocognitive functioning. J Acquir Immune Defic Syndr 36:562–566

    Article  PubMed  Google Scholar 

  • Robertson KR, Nakasujja N, Wong M, Musisi S, Katabira E, Parsons TD, Ronald A, Sacktor N (2007a) Pattern of neuropsychological performance among HIV-positive patients in Uganda. BMC Neurol 7:8

    Article  PubMed Central  PubMed  Google Scholar 

  • Robertson KR, Smurzynski M, Parsons TD, Wu K, Bosch RJ, Wu J, McArthur JC, Collier AC, Evans SR, Ellis RJ (2007b) The prevalence and incidence of neurocognitive impairment in the HAART era. AIDS 21:1915–1921

    Article  PubMed  Google Scholar 

  • Robertson K, Liner J, Meeker RB (2012a) Antiretroviral neurotoxicity. J Neurovirol 18:388–399

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Robertson K, Jiang H, Kumwenda J, Supparatpinyo K, Evans S, Campbell TB, Price R, Tripathy S, Kumarasamy N, La Rosa A, Santos B et al (2012b) Improved neuropsychological and neurological functioning across three antiretroviral regimens in diverse resource-limited settings: AIDS clinical trials group study A5199, the international neurological study. Clin Infect Dis 55:868–876

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Sacktor NC, Lyles RH, Skolasky RL, Anderson DE, McArthur JC, McFarlane G, Selnes OA, Becker JT, Cohen B, Wesch J, Miller EN (1999) Combination antiretroviral therapy improves psychomotor speed performance in HIV-seropositive homosexual men. Multicenter AIDS Cohort Study (MACS). Neurology 52:1640–1647

    Article  CAS  PubMed  Google Scholar 

  • Sacktor N, Lyles RH, Skolasky R, Kleeberger C, Selnes OA, Miller EN, Becker JT, Cohen B, McArthur JC, Multicenter AIDS Cohort Study (2001) HIV-associated neurologic disease incidence changes: multicenter AIDS cohort study, 1990–1998. Neurology 56:257–260

    Article  CAS  PubMed  Google Scholar 

  • Sacktor N, Skolasky RL, Tarwater PM, McArthur JC, Selnes OA, Becker J, Cohen B, Visscher B, Miller EN, Multicenter AIDS Cohort Study (MACS) (2003) Response to systemic HIV viral load suppression correlates with psychomotor speed performance. Neurology 26:567–569

    Article  Google Scholar 

  • Satishchandra P, Nalini A, Gourie-Devi M, Khanna N, Santosh V, Ravi V, Desai A, Chandramuki A (2000) Profile of neurologic disorders associated with HIV/AIDS from Bangalore, south India (1989–96). Indian J Med Res 111:14–23

    CAS  PubMed  Google Scholar 

  • Valcour VG, Ananworanich J, Agsalda M, Sailasuta N, Chalermchai T, Schuetz A, Shikuma C, Liang CY, Jirajariyavej S, Sithinamsuwan P, Tipsuk S, Clifford DB, Paul R, Fletcher JL, Marovich MA, Slike BM, DeGruttola V, Shiramizu B, SEARCH 011 Protocol Team (2013) HIV DNA reservoir increases risk for cognitive disorders in cART-naïve patients. PLoS One 8:e70164

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Wadia RS, Pujari SN, Kothari S, Udhar M, Kulkarni S, Bhagat S, Nanivadekar A (2001) Neurological manifestations of HIV disease. J Assoc Physicians India 49:343–348

    CAS  PubMed  Google Scholar 

  • Yepthomi T, Paul R, Vallabhaneni S, Kumarasamy N, Tate DF, Solomon S, Flanigan T (2006) Neurocognitive consequences of HIV in southern India: a preliminary study of clade C virus. J Int Neuropsychol Soc 12:424–430

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

This research was supported by the National Institute of Mental Health (NIMH) R01 MH78748 NeuroAIDS in India (Dr. Marcotte, P.I.) and P30 MH62512 HIV Neurobehavioral Research Center (Dr. Grant, P.I.).

Conflict of interest

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Manisha Ghate.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ghate, M., Mehendale, S., Meyer, R. et al. The effects of antiretroviral treatment initiation on cognition in HIV-infected individuals with advanced disease in Pune, India. J. Neurovirol. 21, 391–398 (2015). https://doi.org/10.1007/s13365-015-0329-z

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13365-015-0329-z

Keywords

Navigation